T1	PROC 57 68	tratamiento
#1	AnnotatorNotes T1	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T2	DISO 91 117	enfermedad aterosclerótica
#2	AnnotatorNotes T2	C0004153; Atherosclerosis; Disease or Syndrome
T3	DISO 121 140	artritis reumatoide
#3	AnnotatorNotes T3	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T4	PROC 174 185	tratamiento
#4	AnnotatorNotes T4	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T5	DISO 209 235	enfermedad aterosclerótica
#5	AnnotatorNotes T5	C0004153; Atherosclerosis; Disease or Syndrome
T6	CHEM 190 199	sarilumab
#6	AnnotatorNotes T6	C3885145; sarilumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T7	PROC 249 285	Tomografía por Emisión de Positrones
#7	AnnotatorNotes T7	C0032743; Positron-Emission Tomography; Diagnostic Procedure
T8	PROC 288 308	Tomografía computada
#8	AnnotatorNotes T8	C0040405; X-Ray Computed Tomography; Diagnostic Procedure
T9	PROC 335 338	PET
#9	AnnotatorNotes T9	C0032743; Positron-Emission Tomography; Diagnostic Procedure
T10	CHEM 72 81	sarilumab
#10	AnnotatorNotes T10	C3885145; sarilumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T11	DISO 346 365	artritis reumatoide
#11	AnnotatorNotes T11	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T12	DISO 389 408	ARTRITIS REUMATOIDE
#12	AnnotatorNotes T12	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T13	DISO 455 457	AR
#13	AnnotatorNotes T13	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T14	CHEM 513 530	DMARDs biológicos
#14	AnnotatorNotes T14	C4055380; Biologic Disease-Modifying Antirheumatic Drug; Pharmacologic Substance
T15	CHEM 583 601	fármacos anti-IL-6
T16	PROC 626 629	PET
#15	AnnotatorNotes T16	C0032743; Positron-Emission Tomography; Diagnostic Procedure
T17	CHEM 770 779	sarilumab
#16	AnnotatorNotes T17	C3885145; sarilumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T18	DISO 663 669	placas
#17	AnnotatorNotes T18	C0332461; Plaque (lesion); Finding
T19	ANAT 699 707	carótida
T20	PROC 686 707	ecografía de carótida
T21	DISO 942 952	eventos CV
T22	ANAT 950 952	CV
#18	AnnotatorNotes T22	C0007226; Cardiovascular system; Body System | C3887460; Cardiovascular; Body Location or Region
T23	DISO 967 975	diabetes
#19	AnnotatorNotes T23	C0011849; Diabetes Mellitus; Disease or Syndrome | C1802373; Diabetes mellitus (incl subtypes); Disease or Syndrome
T24	DISO 978 997	fallo renal crónico
#20	AnnotatorNotes T24	C0403447; Chronic Kidney Insufficiency; Disease or Syndrome | C1561643; Chronic Kidney Diseases; Disease or Syndrome
T25	PROC 1001 1033	Recuento absoluto de neutrófilos
#21	AnnotatorNotes T25	C0948762; Absolute neutrophil count; Laboratory Procedure
T26	ANAT 1059 1068	plaquetas
#22	AnnotatorNotes T26	C0005821; Blood Platelets; Cell
T27	PROC 1085 1098	Transaminasas
#23	AnnotatorNotes T27	C0919834; Transaminase Assay; Laboratory Procedure
T28	DISO 1135 1144	Infección
#24	AnnotatorNotes T28	C0009450; Communicable Diseases; Disease or Syndrome | C3714514; Infection; Pathologic Function
T29	CHEM 1238 1247	sarilumab
#25	AnnotatorNotes T29	C3885145; sarilumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T30	DISO 1164 1187	infecciones localizadas
#26	AnnotatorNotes T30	C0016397; Focal Infection; Disease or Syndrome
T31	PROC 1292 1306	ensayo clínico
#27	AnnotatorNotes T31	C0008976; Clinical Trials; Research Activity
T32	PROC 1388 1402	consentimiento
#28	AnnotatorNotes T32	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T33	PROC 1508 1529	método anticonceptivo
#29	AnnotatorNotes T33	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T34	PROC 339 341	CT
#30	AnnotatorNotes T34	C0040405; X-Ray Computed Tomography; Diagnostic Procedure
T35	PROC 490 493	PCR
#31	AnnotatorNotes T35	C0201657; C-reactive protein measurement; Laboratory Procedure
T36	PROC 630 632	CT
#32	AnnotatorNotes T36	C0040405; X-Ray Computed Tomography; Diagnostic Procedure
T37	PROC 870 894	consentimiento informado
#33	AnnotatorNotes T37	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T38	ANAT 984 989	renal
#34	AnnotatorNotes T38	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T39	ANAT 1022 1033	neutrófilos
#35	AnnotatorNotes T39	C0027950; neutrophil; Cell
T40	PROC 1047 1068	Recuento de plaquetas
#36	AnnotatorNotes T40	C0032181; Platelet Count measurement; Laboratory Procedure
T41	PROC 1109 1112	ALT
#37	AnnotatorNotes T41	C0201836; Alanine aminotransferase measurement; Laboratory Procedure
T42	PROC 1115 1118	AST
#38	AnnotatorNotes T42	C0201899; Aspartate aminotransferase measurement; Laboratory Procedure
T43	PROC 1220 1234	administración
#39	AnnotatorNotes T43	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T44	Date 13 17	2019
T45	Age 442 450	≥18 años
T47	LIVB 639 648	pacientes
#40	AnnotatorNotes T47	C0030705; Patients; Patient or Disabled Group
T49	LIVB 732 741	Pacientes
#41	AnnotatorNotes T49	C0030705; Patients; Patient or Disabled Group
T50	LIVB 846 855	Pacientes
#42	AnnotatorNotes T50	C0030705; Patients; Patient or Disabled Group
T51	Duration 990 997	crónico
#43	AnnotatorNotes T51	C0205191; chronic; Temporal Concept
T52	LIVB 1251 1260	Pacientes
#44	AnnotatorNotes T52	C0030705; Patients; Patient or Disabled Group
T54	Neg_cue 1338 1348	Negativa a
T55	LIVB 1406 1451	Mujeres embarazadas o en periodo de lactancia
#45	AnnotatorNotes T55	C0033011; Pregnant Women; Population Group | C4316174; Patients who are breastfeeding; Patient or Disabled Group
T56	LIVB 1464 1486	mujeres en edad fértil
#46	AnnotatorNotes T56	C4324275; Woman of childbearing potential; Population Group
T57	Age 1475 1486	edad fértil
T58	PHYS 1414 1425	embarazadas
#47	AnnotatorNotes T58	C0032961; Pregnancy; Organism Function
T59	Neg_cue 1491 1493	no
T46	Neg_cue 505 512	Naïve a
T48	PHYS 1442 1451	lactancia
#48	AnnotatorNotes T48	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T53	DISO 1085 1107	Transaminasas elevadas
#49	AnnotatorNotes T53	C5384817; Elevation of levels of liver transaminase levels; Finding [ICD-10: R74.01]
A1	Assertion T32 Negated
A2	Status T14 History_of
A3	Assertion T14 Negated
A4	Status T21 History_of
A5	Status T23 History_of
A6	Status T24 History_of
A7	Assertion T43 Contraindicated
A8	Assertion T29 Contraindicated
A9	Assertion T33 Negated
A10	Population_data T56 Age
#50	AnnotatorNotes T19	C0007272; Carotid Arteries; Body Part, Organ, or Organ Component
T60	Observation 1349 1373	participar en el estudio
A11	Assertion T60 Negated
#51	AnnotatorNotes T60	C1278516; Patient participation status; Finding
R1	Negation Arg1:T54 Arg2:T60	
R2	Negation Arg1:T54 Arg2:T32	
T61	CONC 466 471	DAS28
#52	AnnotatorNotes T61	C2732493; Disease activity score 28 joint in rheumatoid arthritis; Intellectual Product
T62	Result_or_Value 472 476	>3.2
T63	Result_or_Value 494 502	≥1 mg/dL
R3	Has_Result_or_Value Arg1:T35 Arg2:T63	
R4	Has_Result_or_Value Arg1:T61 Arg2:T62	
T64	Quantifier_or_Qualifier 458 464	activa
#53	AnnotatorNotes T64	C0679217; Active State; Idea or Concept
R5	Has_Quantifier_or_Qualifier Arg1:T13 Arg2:T64	
R6	Negation Arg1:T46 Arg2:T14	
R7	Used_for Arg1:T10 Arg2:T1	
R8	Used_for Arg1:T6 Arg2:T4	
R9	Overlap Arg1:T2 Arg2:T3	
R14	Overlap Arg1:T5 Arg2:T11	
R19	Before Arg1:T32 Arg2:T60	
T65	Observation 1271 1334	participando en otro ensayo clínico o proyecto de investigación
R21	Experiences Arg1:T55 Arg2:T58	
R22	Experiences Arg1:T55 Arg2:T48	
R23	Has_Age Arg1:T56 Arg2:T57	
R24	Negation Arg1:T59 Arg2:T33	
T66	Quantifier_or_Qualifier 1530 1536	eficaz
#54	AnnotatorNotes T66	C1704419; Effective; Qualitative Concept
R25	Has_Quantifier_or_Qualifier Arg1:T33 Arg2:T66	
R26	Negation Arg1:T59 Arg2:T66	
A12	Assertion T66 Negated
R27	Location_of Arg1:T19 Arg2:T20	
#55	AnnotatorNotes T20	C5430445; X-ray of carotid artery; Diagnostic Procedure
R28	Before Arg1:T20 Arg2:T36	
R29	Before Arg1:T20 Arg2:T16	
R32	Experiences Arg1:T47 Arg2:T18	
R33	Experiences Arg1:T47 Arg2:T16	
R34	Experiences Arg1:T47 Arg2:T36	
T67	Result_or_Value 712 727	al menos 1.5 mm
R35	Has_Result_or_Value Arg1:T18 Arg2:T67	
R36	Experiences Arg1:T47 Arg2:T20	
R37	Experiences Arg1:T49 Arg2:T17	
R38	Location_of Arg1:T22 Arg2:T21	
#56	AnnotatorNotes T21	C1320716; Cardiovascular event; Finding
R39	Location_of Arg1:T38 Arg2:T24	
R40	Has_Duration_or_Interval Arg1:T24 Arg2:T51	
T68	Result_or_Value 1034 1043	<2 x109/L
R41	Has_Result_or_Value Arg1:T25 Arg2:T68	
T69	Result_or_Value 1069 1082	<150 x 103/μL
R42	Has_Result_or_Value Arg1:T40 Arg2:T69	
T70	Result_or_Value 1119 1130	> 1,5 x LSN
R43	Has_Result_or_Value Arg1:T42 Arg2:T70	
R44	Has_Result_or_Value Arg1:T41 Arg2:T70	
R45	Has_Result_or_Value Arg1:T27 Arg2:T70	
T71	Quantifier_or_Qualifier 1145 1151	activa
#57	AnnotatorNotes T71	C0679217; Active State; Idea or Concept
R46	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T71	
R47	Used_for Arg1:T29 Arg2:T43	
#58	AnnotatorNotes T15	C5690764; Interleukin-6 Inhibitors; Organic Chemical · Pharmacologic Substance
T72	Observation 533 545	refractarios
#59	AnnotatorNotes T72	C0438286; Absent response to treatment; Finding
A13	Experiencer T52 Patient
A14	Experiencer T55 Patient
A15	Experiencer T56 Patient
A16	Experiencer T47 Patient
A17	Experiencer T49 Patient
A18	Experiencer T50 Patient
A19	Status T17 Future
T73	Observation 46 52	Efecto
#60	AnnotatorNotes T73	C1518681; Outcome of Therapy; Finding (?)
R10	Causes Arg1:T1 Arg2:T73	
T74	Observation 163 169	Efecto
#61	AnnotatorNotes T74	C1518681; Outcome of Therapy; Finding (?)
R11	Causes Arg1:T4 Arg2:T74	
